Refine
Departments, institutes and facilities
Document Type
- Conference Object (13)
- Article (4)
Has Fulltext
- no (17)
Keywords
- Katamnese (1)
- Outcome (1)
- Outcomeforschung (1)
- Patient-Reported Outcomes (PRO) (1)
- Qualitätsmanagement (1)
- Qualitätssicherung (1)
- Qualitätssteuerung (1)
- Rehabilitandenbefragung (1)
Rehabilitation wirkt
(2014)
Die medizinische Rehabilitation bildet im bundesdeutschen Gesundheitssystem eine wichtige Säule. Sie wird weltweit immer wieder als vorbildlich angesehen und ist im internationalen Vergleich mit Mitteln, Infrastruktur, Know-how und Behandlungsqualität hervorragend ausgestattet. Dies ist gut so, aber ist es gut genug?
BACKGROUND
Clinical presentation and disease severity in disorders of purine and pyrimidine metabolism vary considerably. We present a method that allows comprehensive, sensitive, and specific diagnosis of the entire spectrum of abnormalities in purine and pyrimidine metabolism in 1 analytical run.
METHODS
We used reversed-phase HPLC electrospray ionization tandem mass spectrometry to investigate 24 metabolites of purine and pyrimidine metabolism in urine samples from healthy persons and from patients with confirmed diagnoses of inherited metabolic disorders. Urine samples were filtered and diluted to a creatinine concentration of 0.5 mmol/L. Stable-isotope-labeled internal standards were used for quantification. The metabolites were analyzed by multiple-reaction monitoring in positive and negative ionization modes.
RESULTS
Total time of analysis was 20 min. Recovery (n = 8) of a compound after addition of a known concentration was 85%-133%. The mean intraday variation (n = 10) was 12%. The interday variation (n = 7) was < or =17%. Age-related reference intervals were established for each compound. Analysis of patient urine samples revealed major differences in tandem mass spectrometry profiles compared with those of control samples. Twelve deficiencies were reliably detected: hypoxanthine guanine phosphoribosyl transferase, xanthine dehydrogenase, purine nucleoside phosphorylase, adenylosuccinate lyase, uridine monophosphate synthase, adenosine deaminase, adenine phosphoribosyl transferase, molybdenum cofactor, thymidine phosphorylase, dihydropyrimidine dehydrogenase, dihydropyrimidinase, and beta-ureidopropionase.
CONCLUSION
This method enables reliable detection of 13 defects in purine and pyrimidine metabolism in a single analytical run.